Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This randomized phase II trial is studying two different regimens of combination chemotherapy and comparing them to see how well they work in treating patients with high-risk primary stage II or stage III breast cancer.
Key facts
- Study ID
- NCT00004092
- Run by
- City of Hope Medical Center
- People needed
- 72
- Starts
- 1999-05-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2015-08-04
Who can join
Age: any, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner Good Samaritan Medical Center — Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.